BamSEC and AlphaSense Join Forces
Learn More

Abbott Laboratories

NYSE: ABT    
Share price (11/21/24): $117.26    
Market cap (11/21/24): $203 billion

Indentures Filter

EX-4.36
from 10-K 2 pages Description of the Registrant’s Common Shares Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 20 pages Abbott Laboratories Officers’ Certificate Pursuant to Sections 3.1 and 3.3 of the Indenture
12/34/56
EX-4.34
from 10-K 2 pages Description of the Registrant’s Common Shares Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 52 pages Abbott Ireland Financing Dac Supplemental Indenture No. 2 €590,000,000 0.100% Notes Due 2024 €590,000,000 0.375% Notes Due 2027
12/34/56
EX-4.2
from 8-K 71 pages Abbott Ireland Financing Dac Supplemental Indenture No. 1 € 1,140,000,000 0.000% Notes Due 2020 € 1,140,000,000 0.875% Notes Due 2023 € 1,140,000,000 1.500% Notes Due 2026
12/34/56
EX-4.1
from 8-K 73 pages Abbott Ireland Financing Dac and Abbott Laboratories, as Parent Guarantor and U.S. Bank National Association, as Trustee Indenture Dated as of September 27, 2018
12/34/56
EX-4.7
from 10-Q 42 pages Abbott Laboratories Officers’ Certificate Pursuant to Sections 3.1 and 3.3 of the Indenture
12/34/56
EX-4.6
from 8-K 7 pages Form of 2043 Notes Abbott Laboratories 4.75% Senior Note Due 2043
12/34/56
EX-4.5
from 8-K 7 pages Form of 2025 Notes Abbott Laboratories 3.875% Senior Note Due 2025
12/34/56
EX-4.4
from 8-K 7 pages Form of 2023 Notes Abbott Laboratories 3.25% Senior Note Due 2023
12/34/56
EX-4.3
from 8-K 7 pages Form of 2020 Notes Abbott Laboratories 2.800% Senior Note Due 2020
12/34/56
EX-4.2
from 8-K 7 pages Form of 2018 Notes Abbott Laboratories 2.000% Senior Note Due 2018
12/34/56
EX-4.3
from S-4 6 pages Seventh Supplemental Indenture
12/34/56
EX-4.2
from S-4 37 pages Abbott Laboratories Officers’ Certificate Pursuant to Sections 3.1 and 3.3 of the Indenture
12/34/56
EX-4.22
from 10-K 50 pages Abbott Laboratories Officers’ Certificate Pursuant to Sections 3.1 and 3.3 of the Indenture
12/34/56
EX-4.7
from 8-K 8 pages Form of 2046 Notes Abbott Laboratories 4.900% Note Due 2046
12/34/56
EX-4.6
from 8-K 8 pages Form of 2036 Notes Abbott Laboratories 4.750% Note Due 2036
12/34/56
EX-4.5
from 8-K 8 pages Form of 2026 Notes Abbott Laboratories 3.750% Note Due 2026
12/34/56
EX-4.4
from 8-K 8 pages Form of 2023 Notes Abbott Laboratories 3.400% Note Due 2023
12/34/56
EX-4.3
from 8-K 7 pages Form of 2021 Notes Abbott Laboratories 2.900% Note Due 2021
12/34/56